328 results on '"Rawal, Bhupendra"'
Search Results
2. Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial
3. Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy
4. Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation
5. Nutritional Assessment and Malnutrition in Patients With Cirrhosis
6. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences
7. Novel Evidence-Based Classification of Cavernous Venous Occlusive Disease
8. The use of passive visual stimuli to enhance compliance with handwashing in a perioperative setting
9. Supplementary Figure 1 from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
10. Supplementary Figure 3 from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
11. Data from Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
12. Supplementary Figure 2 from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
13. Supplementary Figure Legends from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
14. Supplementary Data from Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
15. Supplementary Figure 5 from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
16. Supplementary Figure 4 from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
17. Data from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
18. Supplementary Tables 1 - 2 from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
19. Supplementary Table 3A - B from Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer
20. Supplementary Methods from β-Arrestin-1 Mediates Nicotine-Induced Metastasis through E2F1 Target Genes That Modulate Epithelial–Mesenchymal Transition
21. Data from β-Arrestin-1 Mediates Nicotine-Induced Metastasis through E2F1 Target Genes That Modulate Epithelial–Mesenchymal Transition
22. Supplementary Figures 1 - 10, Tables 1 - 3 from β-Arrestin-1 Mediates Nicotine-Induced Metastasis through E2F1 Target Genes That Modulate Epithelial–Mesenchymal Transition
23. Survival After Lung Retransplantation in the United States in the Current Era (2004 to 2013): Better or Worse?
24. Very Early Mobilization in Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator
25. The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy
26. Long-term Results of Aortouniiliac Stent Grafts for the Endovascular Repair of Abdominal Aortic Aneurysms
27. Preoperative risk factors predict survival following cardiac retransplantation: Analysis of the United Network for Organ Sharing database
28. Assessment of Virtual Reality Robotic Simulation Performance by Urology Resident Trainees
29. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema
30. 778 Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in “cold” and I-O refractory metastatic solid tumors
31. Safety of capsule endoscopy in the octogenarian as compared with younger patients
32. Tripartite Motif Containing 28 (Trim28) Can Regulate Cell Proliferation by Bridging HDAC1/E2F Interactions
33. Impact of fellowship training on robotic-assisted laparoscopic partial nephrectomy: benchmarking perioperative safety and outcomes
34. Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate Cancer
35. Salvage brachytherapy for multiply recurrent metastatic brain tumors: a matched-case analysis
36. Incremental Risk Associated with Contralateral Prophylactic Mastectomy and the Effect on Adjuvant Therapy
37. Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer
38. Salvage autologous fascial sling after failed synthetic midurethral sling: Greater than 3-year outcomes
39. Head and Neck Cancer Clinical Research on ClinicalTrials.gov: An Opportunity for Radiation Oncologists
40. Is mastectomy undertreatment for low-risk breast cancers eligible for breast-conserving therapy?
41. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
42. MP81-10 LONG-TERM RESULTS OF SALVAGE AUTOLOGOUS FASCIAL SLING PLACEMENT FOLLOWING FAILED SYNTHETIC MIDURETHRAL SLING FOR STRESS URINARY INCONTINENCE IN WOMEN
43. MP51-19 COLOR DUPLEX DOPPLER ULTRASOUND (CDDU): CAN WE CATEGORIZE CAVERNOUS VENOUS OCCLUSIVE DISEASE (CVOD) AS MILD, MODERATE AND SEVERE?
44. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry
45. Factors Affecting Lymph Node Yield in Patients Undergoing Axillary Node Dissection for Primary Breast Cancer: A Single-Institution Review
46. A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities
47. Pancreatic Fistula Rates After 462 Distal Pancreatectomies: Staplers Do Not Decrease Fistula Rates
48. Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer (041)
49. Ultrathin primary is a marker for worse prognosis in lymph node–positive cutaneous melanoma
50. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.